Identification and pharmacological profile of SPP1, a potent, functionally selective and brain penetrant agonist at muscarinic M1 receptors-Reference-Cited by-同舟云学术

Identification and pharmacological profile of SPP1, a potent, functionally selective and brain penetrant agonist at muscarinic M1 receptors

Published:2018-11-16 Issue:1 Volume:176 Page:110-126
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:British Journal of Pharmacology

Author:

Broad Lisa M¹,Sanger Helen E¹,Mogg Adrian J¹^ORCID,Colvin Ellen M¹,Zwart Ruud¹,Evans David A¹,Pasqui Francesca¹,Sher Emanuele¹,Wishart Graham N¹,Barth Vanessa N²,Felder Christian C²,Goldsmith Paul J¹

Affiliation:

1. Eli Lilly and Company, Lilly Research Centre; Windlesham Surrey UK

2. Eli Lilly and Company, Lilly Corporate Center; Indianapolis IN USA

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bph.14510/fullpdf

Reference62 articles.

1. Molecular determinants of allosteric modulation at the M1 muscarinic acetylcholine receptor;Abdul-Ridha;J Biol Chem,2014

2. The Concise Guide to PHARMACOLOGY 2017/18: G protein-coupled receptors;Alexander;Br J Pharmacol,2017a

3. The Concise Guide to PHARMACOLOGY 2017/18: Enzymes;Alexander;Br J Pharmacol,2017b

4. The Concise Guide to PHARMACOLOGY 2017/18: Transporters;Alexander;Br J Pharmacol,2017c

5. Capabilities of the WinLTP data acquisition program extending beyond basic LTP experimental functions;Anderson;J Neurosci Methods,2007

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. M1/M4 receptors as potential therapeutic treatments for schizophrenia: A comprehensive study;Bioorganic & Medicinal Chemistry;2024-05

2. Multitargeting nature of muscarinic orthosteric agonists and antagonists;Frontiers in Physiology;2022-09-06

3. Targeting the M1 muscarinic acetylcholine receptor in Alzheimer’s disease;Neuronal Signaling;2022-04

4. Recent in vivo advances of spirocyclic scaffolds for drug discovery;Expert Opinion on Drug Discovery;2022-03-25

5. Drug Design Targeting the Muscarinic Receptors and the Implications in Central Nervous System Disorders;Biomedicines;2022-02-07